RSS

high potency APIs

With the industry experiencing dramatic change, from regulatory changes to investments in capacity and the uncertainty of the political landscape, we asked several industry heads to review the opportunities, challenges and trends of 2017. more

Opinion

Demand for high potent active pharmaceutical ingredients is driving the need for high potency handling capabilities. Here, Mike Avraam, global product manager for ChargePoint PharmaSafe, ChargePoint Technology, discusses this growing sector in detail more

Opinion

Cambrex, a manufacturer of small molecule innovator and generic active pharmaceutical ingredients (APIs), is investing $24 million in a new highly potent API manufacturing facility in Charles City, Iowa. more

News

Jörg Gierds, Fette Compacting looks at the rising demands on tablet presses for highly potent agents and explains how efficiency can be achieved through seamless containment more

Opinion

A large-scale spray drying unit specifically designed to handle high potency APIs and for use with a wide variety of organic solvent systems is to be installed at Hovione's new spray drying facility in Loures, Portugal. more

News